Boehringer Ingelheim group is one of the world¡¯s 20 leading pharmaceutical companies. Boehringer Ingelheim Korea is Korean subsidiary of Boehringer Ingleheim group. It was founded in 1976 and around 280 employees are working at BIKR. The core products are TWYNSTA,PRADAXA,TRAJENTA,MICARDIS,SPIRIVA.
CardioVascular Research Foundation(CVRF)
2nd Floor, Asan Institute for Education & Research,
88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea
Business registration number: 215-82-06387
Copyright ¨Ï 2002 CVRF, Seoul, Korea. All rights reserved.